Significant Ownership of Leonite Fund I, LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Leonite Fund I, LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- Avi Geller - Chief Investment Officer
- Manager location
- Spring Valley, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Leonite Fund I, LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Leonite Fund I, LP
Significant Ownership of Leonite Fund I, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MEHA | Functional Brands Inc. | Common Shares, $0.00001 par value per share | 8.8% | $412,096 | 2,289,424 | Leonite Fund I, LP | 04 May 2026 | ||
| RSLS | ReShape Lifesciences Inc. | Common Shares, $0.001 par value per share | 6.1% | $76,000 | 200,000 | Leonite Fund I, LP | 18 Feb 2025 | ||
| HSDT | HELIUS MEDICAL TECHNOLOGIES, INC. | Common Shares, $0.001 par value per share | 5.2% | $699,506 | 163,055 | Leonite Fund I, LP | 05 Jun 2025 |
Schedules 13D/G Reported by Leonite Fund I, LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.